

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | piRNA metabolic process (GO:0034587) | 6.47707796 |
| 2 | regulation of meiosis I (GO:0060631) | 4.88700986 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 4.71764909 |
| 4 | synapsis (GO:0007129) | 4.54666172 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.53389356 |
| 6 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.40548932 |
| 7 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.26807475 |
| 8 | inositol phosphate dephosphorylation (GO:0046855) | 4.26807475 |
| 9 | inositol phosphate catabolic process (GO:0071545) | 4.25960709 |
| 10 | vocalization behavior (GO:0071625) | 4.21905318 |
| 11 | protein localization to synapse (GO:0035418) | 4.20871487 |
| 12 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.19425175 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.12341796 |
| 14 | DNA methylation involved in gamete generation (GO:0043046) | 4.11376494 |
| 15 | regulation of DNA endoreduplication (GO:0032875) | 4.08572874 |
| 16 | mitotic sister chromatid cohesion (GO:0007064) | 4.05324516 |
| 17 | positive regulation of action potential (GO:0045760) | 4.04942754 |
| 18 | protein targeting to Golgi (GO:0000042) | 3.98734321 |
| 19 | neuronal action potential propagation (GO:0019227) | 3.98259344 |
| 20 | establishment of protein localization to Golgi (GO:0072600) | 3.94189393 |
| 21 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.87296870 |
| 22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.83357334 |
| 23 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.81695285 |
| 24 | polyol catabolic process (GO:0046174) | 3.78827773 |
| 25 | tachykinin receptor signaling pathway (GO:0007217) | 3.76417203 |
| 26 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.73386154 |
| 27 | positive regulation of synapse maturation (GO:0090129) | 3.69536923 |
| 28 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.68312151 |
| 29 | chaperone-mediated protein transport (GO:0072321) | 3.67161607 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.53778921 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.53396196 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 3.51714582 |
| 33 | dopamine transport (GO:0015872) | 3.49093107 |
| 34 | glutamate secretion (GO:0014047) | 3.48151909 |
| 35 | neuron recognition (GO:0008038) | 3.47824244 |
| 36 | response to nitrosative stress (GO:0051409) | 3.47157498 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.43777834 |
| 38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.43584437 |
| 39 | relaxation of smooth muscle (GO:0044557) | 3.41858819 |
| 40 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.41662532 |
| 41 | positive regulation of vasculogenesis (GO:2001214) | 3.40035795 |
| 42 | magnesium ion transport (GO:0015693) | 3.38822553 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.38014625 |
| 44 | regulation of glucokinase activity (GO:0033131) | 3.32077849 |
| 45 | regulation of hexokinase activity (GO:1903299) | 3.32077849 |
| 46 | regulation of synaptic vesicle transport (GO:1902803) | 3.29730682 |
| 47 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.27934001 |
| 48 | Golgi to endosome transport (GO:0006895) | 3.25909171 |
| 49 | male meiosis (GO:0007140) | 3.25697846 |
| 50 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25459848 |
| 51 | gene silencing by RNA (GO:0031047) | 3.25275395 |
| 52 | neural tube formation (GO:0001841) | 3.20757672 |
| 53 | neuron-neuron synaptic transmission (GO:0007270) | 3.20233411 |
| 54 | sister chromatid cohesion (GO:0007062) | 3.19142252 |
| 55 | behavioral fear response (GO:0001662) | 3.17489609 |
| 56 | behavioral defense response (GO:0002209) | 3.17489609 |
| 57 | protein localization to Golgi apparatus (GO:0034067) | 3.15572434 |
| 58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.12016784 |
| 59 | proteasome assembly (GO:0043248) | 3.11788328 |
| 60 | regulation of synapse maturation (GO:0090128) | 3.11333986 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.10961257 |
| 62 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.10617334 |
| 63 | ATP synthesis coupled proton transport (GO:0015986) | 3.10617334 |
| 64 | neurotransmitter secretion (GO:0007269) | 3.09792192 |
| 65 | acrosome assembly (GO:0001675) | 3.08683339 |
| 66 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.08021817 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.07757401 |
| 68 | synaptic transmission, glutamatergic (GO:0035249) | 3.07583043 |
| 69 | long-term memory (GO:0007616) | 3.06352458 |
| 70 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.05132668 |
| 71 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.04604467 |
| 72 | prostate gland growth (GO:0060736) | 3.03369124 |
| 73 | peptidyl-cysteine modification (GO:0018198) | 3.03212509 |
| 74 | positive regulation of protein autophosphorylation (GO:0031954) | 3.03004679 |
| 75 | rRNA methylation (GO:0031167) | 3.01879566 |
| 76 | male meiosis I (GO:0007141) | 3.01124600 |
| 77 | axonal fasciculation (GO:0007413) | 3.00847512 |
| 78 | xenobiotic catabolic process (GO:0042178) | 3.00185693 |
| 79 | negative regulation of interleukin-17 production (GO:0032700) | 2.99343405 |
| 80 | fear response (GO:0042596) | 2.99109278 |
| 81 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.98349558 |
| 82 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.98349558 |
| 83 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.98349558 |
| 84 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.97048343 |
| 85 | intra-S DNA damage checkpoint (GO:0031573) | 2.96366356 |
| 86 | nerve growth factor signaling pathway (GO:0038180) | 2.95828838 |
| 87 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.94567456 |
| 88 | synaptic vesicle maturation (GO:0016188) | 2.93058426 |
| 89 | cell migration in hindbrain (GO:0021535) | 2.92022694 |
| 90 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.90126805 |
| 91 | ribonucleoprotein complex disassembly (GO:0032988) | 2.88431045 |
| 92 | positive regulation of synapse assembly (GO:0051965) | 2.88337452 |
| 93 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.87797479 |
| 94 | postsynaptic membrane organization (GO:0001941) | 2.87398952 |
| 95 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84826153 |
| 96 | DNA double-strand break processing (GO:0000729) | 2.84790730 |
| 97 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.82797500 |
| 98 | negative regulation of JUN kinase activity (GO:0043508) | 2.82365143 |
| 99 | smooth muscle tissue development (GO:0048745) | 2.81813702 |
| 100 | establishment of synaptic vesicle localization (GO:0097480) | 2.81273662 |
| 101 | synaptic vesicle transport (GO:0048489) | 2.81273662 |
| 102 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.80576365 |
| 103 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.80163377 |
| 104 | response to histamine (GO:0034776) | 2.79409037 |
| 105 | exploration behavior (GO:0035640) | 2.78501988 |
| 106 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.77083620 |
| 107 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.76801470 |
| 108 | termination of RNA polymerase III transcription (GO:0006386) | 2.76801470 |
| 109 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.76416959 |
| 110 | transmission of nerve impulse (GO:0019226) | 2.74318939 |
| 111 | neurotransmitter catabolic process (GO:0042135) | 2.73500498 |
| 112 | transferrin transport (GO:0033572) | 2.73086932 |
| 113 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.72752608 |
| 114 | 7-methylguanosine mRNA capping (GO:0006370) | 2.71503004 |
| 115 | regulation of platelet aggregation (GO:0090330) | 2.71178556 |
| 116 | neurotransmitter transport (GO:0006836) | 2.71042739 |
| 117 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.70449122 |
| 118 | startle response (GO:0001964) | 2.70342456 |
| 119 | organelle disassembly (GO:1903008) | 2.70261961 |
| 120 | positive regulation of interferon-beta production (GO:0032728) | 2.70165270 |
| 121 | establishment of vesicle localization (GO:0051650) | 2.70002662 |
| 122 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.69439429 |
| 123 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.69439429 |
| 124 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.69307673 |
| 125 | meiotic cell cycle (GO:0051321) | 2.68878183 |
| 126 | negative regulation of microtubule polymerization (GO:0031115) | 2.68626101 |
| 127 | regulation of glutamate secretion (GO:0014048) | 2.68087551 |
| 128 | positive regulation of macroautophagy (GO:0016239) | 2.66269887 |
| 129 | proline transport (GO:0015824) | 2.65722207 |
| 130 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.65566893 |
| 131 | positive regulation of mitochondrial fission (GO:0090141) | 2.65249387 |
| 132 | growth hormone receptor signaling pathway (GO:0060396) | 2.65021456 |
| 133 | presynaptic membrane assembly (GO:0097105) | 2.64944373 |
| 134 | definitive hemopoiesis (GO:0060216) | 2.64870180 |
| 135 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.64344811 |
| 136 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.64344811 |
| 137 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.64231882 |
| 138 | 7-methylguanosine RNA capping (GO:0009452) | 2.64148626 |
| 139 | RNA capping (GO:0036260) | 2.64148626 |
| 140 | regulation of memory T cell differentiation (GO:0043380) | 2.63505137 |
| 141 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.63228136 |
| 142 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.63228136 |
| 143 | rRNA modification (GO:0000154) | 2.62829458 |
| 144 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.62628638 |
| 145 | layer formation in cerebral cortex (GO:0021819) | 2.62560360 |
| 146 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.61858534 |
| 147 | dendrite development (GO:0016358) | 2.61498773 |
| 148 | regulation of vesicle fusion (GO:0031338) | 2.61312086 |
| 149 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.60978495 |
| 150 | cell wall macromolecule catabolic process (GO:0016998) | 2.60754447 |
| 151 | chromosome organization involved in meiosis (GO:0070192) | 2.60750605 |
| 152 | establishment of melanosome localization (GO:0032401) | 2.59766376 |
| 153 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.59673162 |
| 154 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58801301 |
| 155 | regulation of interleukin-17 production (GO:0032660) | 2.58572266 |
| 156 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.58116003 |
| 157 | keratinocyte development (GO:0003334) | 2.58036994 |
| 158 | cullin deneddylation (GO:0010388) | 2.57865487 |
| 159 | regulation of postsynaptic membrane potential (GO:0060078) | 2.56534680 |
| 160 | social behavior (GO:0035176) | 2.56207067 |
| 161 | intraspecies interaction between organisms (GO:0051703) | 2.56207067 |
| 162 | behavioral response to cocaine (GO:0048148) | 2.55071083 |
| 163 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.54812752 |
| 164 | reciprocal DNA recombination (GO:0035825) | 2.54658117 |
| 165 | reciprocal meiotic recombination (GO:0007131) | 2.54658117 |
| 166 | presynaptic membrane organization (GO:0097090) | 2.54348588 |
| 167 | regulation of interferon-alpha production (GO:0032647) | 2.54039882 |
| 168 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.54033780 |
| 169 | dendritic spine morphogenesis (GO:0060997) | 2.53609780 |
| 170 | protein neddylation (GO:0045116) | 2.53329713 |
| 171 | establishment of protein localization to mitochondrion (GO:0072655) | 2.53043447 |
| 172 | neuromuscular process controlling posture (GO:0050884) | 2.53030589 |
| 173 | protein deneddylation (GO:0000338) | 2.52996862 |
| 174 | positive regulation of natural killer cell activation (GO:0032816) | 2.52535442 |
| 175 | negative regulation of meiotic cell cycle (GO:0051447) | 2.52523161 |
| 176 | female gonad development (GO:0008585) | 2.52460607 |
| 177 | regulation of neurotransmitter levels (GO:0001505) | 2.51920530 |
| 178 | protein targeting to mitochondrion (GO:0006626) | 2.51687360 |
| 179 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.51638382 |
| 180 | cerebellar granule cell differentiation (GO:0021707) | 2.51415564 |
| 181 | regulation of neurotransmitter secretion (GO:0046928) | 2.51266413 |
| 182 | genitalia morphogenesis (GO:0035112) | 2.50990248 |
| 183 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.50004423 |
| 184 | serotonin receptor signaling pathway (GO:0007210) | 2.49630811 |
| 185 | synapse assembly (GO:0007416) | 2.49295846 |
| 186 | positive regulation of response to nutrient levels (GO:0032109) | 2.47826167 |
| 187 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.47826167 |
| 188 | glycerophospholipid catabolic process (GO:0046475) | 2.47330577 |
| 189 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.46230517 |
| 190 | protein K11-linked deubiquitination (GO:0035871) | 2.45812011 |
| 191 | ether lipid metabolic process (GO:0046485) | 2.45487733 |
| 192 | thrombin receptor signaling pathway (GO:0070493) | 2.45094036 |
| 193 | adaptation of signaling pathway (GO:0023058) | 2.44605394 |
| 194 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.44338427 |
| 195 | positive regulation of cell cycle G1/S phase transition (GO:1902808) | 2.44222801 |
| 196 | cellular response to dsRNA (GO:0071359) | 2.43704918 |
| 197 | zinc ion transport (GO:0006829) | 2.42286726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.98861234 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.06178928 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21888657 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.73305783 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.62487077 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.58708211 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.43625187 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33126099 |
| 9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.27986738 |
| 10 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.24040779 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21288875 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.18476113 |
| 13 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17099500 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.07924517 |
| 15 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.05586681 |
| 16 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.05582696 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 2.02646164 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02195476 |
| 19 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93666867 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.93041068 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88507000 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.87189253 |
| 23 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.84428742 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.84327013 |
| 25 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.82702655 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82115863 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.76963466 |
| 28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.76842945 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72065096 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71582545 |
| 31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.70343274 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.70343274 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67076023 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.67056307 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66759026 |
| 36 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.66595404 |
| 37 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.64175952 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63409650 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62195847 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62195847 |
| 41 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.60539473 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.60299277 |
| 43 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.60096766 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59605210 |
| 45 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.59578895 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59316645 |
| 47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57322624 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56706405 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54982669 |
| 50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.53195872 |
| 51 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52944604 |
| 52 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.50615300 |
| 53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50023407 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49545857 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48936178 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48668987 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48457629 |
| 58 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.46611809 |
| 59 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.44051762 |
| 60 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44025415 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43874882 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.42415737 |
| 63 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.40807797 |
| 64 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40026619 |
| 65 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37299239 |
| 66 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33925485 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33256436 |
| 68 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.33073910 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32952874 |
| 70 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32848025 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32760043 |
| 72 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.31993836 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31941022 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31930313 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31826937 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30159349 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30147301 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29342271 |
| 79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.28494364 |
| 80 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28156062 |
| 81 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.27294722 |
| 82 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.26567450 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26366711 |
| 84 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.26132795 |
| 85 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24976913 |
| 86 | JUN_21703547_ChIP-Seq_K562_Human | 1.24561644 |
| 87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24530107 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23863422 |
| 89 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.23006688 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21845677 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21562954 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20851061 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20543914 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20358980 |
| 95 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19321549 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18191069 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18191069 |
| 98 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18054857 |
| 99 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17751915 |
| 100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17213798 |
| 101 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.16470174 |
| 102 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16440474 |
| 103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15376396 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15276861 |
| 105 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15276861 |
| 106 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.15046436 |
| 107 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14987974 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14082080 |
| 109 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13460519 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13098390 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12964052 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12548189 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11251305 |
| 114 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11163127 |
| 115 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.10366557 |
| 116 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09299318 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09189028 |
| 118 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08629813 |
| 119 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.07712716 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07416570 |
| 121 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07212322 |
| 122 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07179967 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06659770 |
| 124 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06453963 |
| 125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05880994 |
| 126 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05417822 |
| 127 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04414993 |
| 128 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.04163590 |
| 129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04102129 |
| 130 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03335959 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03027080 |
| 132 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02807207 |
| 133 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02752515 |
| 134 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.02295792 |
| 135 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01512863 |
| 136 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01413866 |
| 137 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00661450 |
| 138 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.00329666 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00311599 |
| 140 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00251017 |
| 141 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.99189645 |
| 142 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99070858 |
| 143 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98673900 |
| 144 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97565558 |
| 145 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96910749 |
| 146 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95447760 |
| 147 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94959240 |
| 148 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94830114 |
| 149 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94504107 |
| 150 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94176146 |
| 151 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93045102 |
| 152 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92159590 |
| 153 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91968953 |
| 154 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90462617 |
| 155 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90462617 |
| 156 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.89538536 |
| 157 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.88896339 |
| 158 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86322255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.16131951 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.22040211 |
| 3 | MP0009697_abnormal_copulation | 4.18398832 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.65419266 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.26092328 |
| 6 | MP0002735_abnormal_chemical_nociception | 3.16080811 |
| 7 | MP0004270_analgesia | 3.05372473 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.01149785 |
| 9 | MP0003195_calcinosis | 2.85927609 |
| 10 | MP0009046_muscle_twitch | 2.85888197 |
| 11 | MP0006276_abnormal_autonomic_nervous | 2.80374728 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.77223935 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.73524700 |
| 14 | MP0009745_abnormal_behavioral_response | 2.69129250 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.56887439 |
| 16 | MP0001529_abnormal_vocalization | 2.52953425 |
| 17 | MP0004147_increased_porphyrin_level | 2.50855051 |
| 18 | MP0002736_abnormal_nociception_after | 2.50357851 |
| 19 | MP0002064_seizures | 2.49525962 |
| 20 | MP0010678_abnormal_skin_adnexa | 2.48227272 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.45843653 |
| 22 | MP0002272_abnormal_nervous_system | 2.42110791 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.32239648 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.29515697 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.29320839 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.17635122 |
| 27 | MP0002184_abnormal_innervation | 2.13573501 |
| 28 | MP0000383_abnormal_hair_follicle | 2.13016406 |
| 29 | MP0004084_abnormal_cardiac_muscle | 2.10160750 |
| 30 | MP0001486_abnormal_startle_reflex | 2.10058127 |
| 31 | MP0000427_abnormal_hair_cycle | 2.07381936 |
| 32 | MP0000778_abnormal_nervous_system | 2.03480802 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 2.02663310 |
| 34 | MP0002733_abnormal_thermal_nociception | 2.02113898 |
| 35 | MP0001970_abnormal_pain_threshold | 2.00544897 |
| 36 | MP0001188_hyperpigmentation | 2.00140677 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 1.99016283 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.96970758 |
| 39 | MP0001984_abnormal_olfaction | 1.95531308 |
| 40 | MP0001905_abnormal_dopamine_level | 1.94452078 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.87045690 |
| 42 | MP0003718_maternal_effect | 1.82776359 |
| 43 | MP0002009_preneoplasia | 1.82260674 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.81796563 |
| 45 | MP0008260_abnormal_autophagy | 1.81501022 |
| 46 | MP0003123_paternal_imprinting | 1.70432182 |
| 47 | MP0003879_abnormal_hair_cell | 1.67939676 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.66110278 |
| 49 | MP0002254_reproductive_system_inflammat | 1.64296057 |
| 50 | MP0005410_abnormal_fertilization | 1.62253367 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.58793344 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.57544054 |
| 53 | MP0004924_abnormal_behavior | 1.57544054 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.54168173 |
| 55 | MP0003329_amyloid_beta_deposits | 1.53348418 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.52871502 |
| 57 | MP0001919_abnormal_reproductive_system | 1.50325529 |
| 58 | MP0003943_abnormal_hepatobiliary_system | 1.46180688 |
| 59 | MP0003315_abnormal_perineum_morphology | 1.43711841 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.43656647 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.41852108 |
| 62 | MP0002822_catalepsy | 1.37901262 |
| 63 | MP0004142_abnormal_muscle_tone | 1.36942984 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.35890851 |
| 65 | MP0001764_abnormal_homeostasis | 1.35634507 |
| 66 | MP0005647_abnormal_sex_gland | 1.35499701 |
| 67 | MP0003303_peritoneal_inflammation | 1.31652131 |
| 68 | MP0000955_abnormal_spinal_cord | 1.31306844 |
| 69 | MP0004811_abnormal_neuron_physiology | 1.30387696 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.27485417 |
| 71 | MP0008877_abnormal_DNA_methylation | 1.25373802 |
| 72 | MP0010368_abnormal_lymphatic_system | 1.24675648 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.24263853 |
| 74 | MP0002102_abnormal_ear_morphology | 1.23407521 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.22720933 |
| 76 | MP0006054_spinal_hemorrhage | 1.21273179 |
| 77 | MP0003950_abnormal_plasma_membrane | 1.20866569 |
| 78 | MP0010386_abnormal_urinary_bladder | 1.17793281 |
| 79 | MP0003122_maternal_imprinting | 1.14462759 |
| 80 | MP0006292_abnormal_olfactory_placode | 1.14257404 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 1.14170484 |
| 82 | MP0005394_taste/olfaction_phenotype | 1.12875689 |
| 83 | MP0005499_abnormal_olfactory_system | 1.12875689 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.12304595 |
| 85 | MP0003252_abnormal_bile_duct | 1.11467451 |
| 86 | MP0003186_abnormal_redox_activity | 1.11312433 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 1.09583551 |
| 88 | MP0002006_tumorigenesis | 1.08667049 |
| 89 | MP0002693_abnormal_pancreas_physiology | 1.07366843 |
| 90 | MP0001145_abnormal_male_reproductive | 1.05824863 |
| 91 | MP0004036_abnormal_muscle_relaxation | 1.05201572 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 1.04820076 |
| 93 | MP0008569_lethality_at_weaning | 1.04735815 |
| 94 | MP0002752_abnormal_somatic_nervous | 1.02379942 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 1.01218291 |
| 96 | MP0002909_abnormal_adrenal_gland | 1.00218535 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.99481084 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.99292341 |
| 99 | MP0002152_abnormal_brain_morphology | 0.97845823 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.97533329 |
| 101 | MP0008789_abnormal_olfactory_epithelium | 0.97497514 |
| 102 | MP0008004_abnormal_stomach_pH | 0.97339530 |
| 103 | MP0002163_abnormal_gland_morphology | 0.97182294 |
| 104 | MP0004742_abnormal_vestibular_system | 0.96263068 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.96222812 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.95467704 |
| 107 | MP0005187_abnormal_penis_morphology | 0.94447415 |
| 108 | MP0003121_genomic_imprinting | 0.92618277 |
| 109 | MP0009764_decreased_sensitivity_to | 0.91892192 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.90543689 |
| 111 | MP0002751_abnormal_autonomic_nervous | 0.88009712 |
| 112 | MP0003787_abnormal_imprinting | 0.87959639 |
| 113 | MP0002160_abnormal_reproductive_system | 0.87778330 |
| 114 | MP0000631_abnormal_neuroendocrine_gland | 0.87767438 |
| 115 | MP0010307_abnormal_tumor_latency | 0.86972726 |
| 116 | MP0005535_abnormal_body_temperature | 0.86084427 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.85124070 |
| 118 | MP0003693_abnormal_embryo_hatching | 0.85074749 |
| 119 | MP0003938_abnormal_ear_development | 0.84682566 |
| 120 | MP0004484_altered_response_of | 0.84483667 |
| 121 | MP0009379_abnormal_foot_pigmentation | 0.83804822 |
| 122 | MP0002229_neurodegeneration | 0.83345698 |
| 123 | MP0001986_abnormal_taste_sensitivity | 0.82874727 |
| 124 | MP0001191_abnormal_skin_condition | 0.82837065 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.78962465 |
| 126 | MP0005253_abnormal_eye_physiology | 0.78860312 |
| 127 | MP0003136_yellow_coat_color | 0.78471304 |
| 128 | MP0000026_abnormal_inner_ear | 0.78357821 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.77288809 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.75505988 |
| 131 | MP0004858_abnormal_nervous_system | 0.74838651 |
| 132 | MP0006035_abnormal_mitochondrial_morpho | 0.74475210 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.72740889 |
| 134 | MP0001119_abnormal_female_reproductive | 0.72576237 |
| 135 | MP0003861_abnormal_nervous_system | 0.71810663 |
| 136 | MP0002166_altered_tumor_susceptibility | 0.70896088 |
| 137 | MP0002069_abnormal_eating/drinking_beha | 0.70691353 |
| 138 | MP0003786_premature_aging | 0.69813194 |
| 139 | MP0004885_abnormal_endolymph | 0.69619374 |
| 140 | MP0001944_abnormal_pancreas_morphology | 0.68782718 |
| 141 | MP0008007_abnormal_cellular_replicative | 0.68473471 |
| 142 | MP0004264_abnormal_extraembryonic_tissu | 0.67897704 |
| 143 | MP0001545_abnormal_hematopoietic_system | 0.67381482 |
| 144 | MP0005397_hematopoietic_system_phenotyp | 0.67381482 |
| 145 | MP0001835_abnormal_antigen_presentation | 0.67332734 |
| 146 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66790197 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.64190290 |
| 148 | MP0005389_reproductive_system_phenotype | 0.64159380 |
| 149 | MP0004085_abnormal_heartbeat | 0.62900090 |
| 150 | MP0008057_abnormal_DNA_replication | 0.62845124 |
| 151 | MP0003698_abnormal_male_reproductive | 0.62839675 |
| 152 | MP0005174_abnormal_tail_pigmentation | 0.62571084 |
| 153 | MP0001929_abnormal_gametogenesis | 0.60795540 |
| 154 | MP0003634_abnormal_glial_cell | 0.60601494 |
| 155 | MP0002210_abnormal_sex_determination | 0.60429092 |
| 156 | MP0005332_abnormal_amino_acid | 0.60044121 |
| 157 | MP0009765_abnormal_xenobiotic_induced | 0.59991198 |
| 158 | MP0006082_CNS_inflammation | 0.58839052 |
| 159 | MP0004957_abnormal_blastocyst_morpholog | 0.58085382 |
| 160 | MP0000653_abnormal_sex_gland | 0.57192843 |
| 161 | MP0008995_early_reproductive_senescence | 0.57164656 |
| 162 | MP0008058_abnormal_DNA_repair | 0.57133385 |
| 163 | MP0000465_gastrointestinal_hemorrhage | 0.55489574 |
| 164 | MP0000230_abnormal_systemic_arterial | 0.55271058 |
| 165 | MP0000604_amyloidosis | 0.55270384 |
| 166 | MP0003699_abnormal_female_reproductive | 0.55150174 |
| 167 | MP0003724_increased_susceptibility_to | 0.54815981 |
| 168 | MP0003191_abnormal_cellular_cholesterol | 0.52631467 |
| 169 | MP0001216_abnormal_epidermal_layer | 0.52537710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.07242800 |
| 2 | Myokymia (HP:0002411) | 4.63483263 |
| 3 | Visual hallucinations (HP:0002367) | 4.37712868 |
| 4 | Atonic seizures (HP:0010819) | 4.11448388 |
| 5 | Focal seizures (HP:0007359) | 4.07877896 |
| 6 | Papillary thyroid carcinoma (HP:0002895) | 3.90811091 |
| 7 | Thyroid carcinoma (HP:0002890) | 3.83656533 |
| 8 | Absence seizures (HP:0002121) | 3.82673175 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.47264925 |
| 10 | Dialeptic seizures (HP:0011146) | 3.45950274 |
| 11 | Abolished electroretinogram (ERG) (HP:0000550) | 3.41374453 |
| 12 | Delusions (HP:0000746) | 3.33753517 |
| 13 | Abnormality of the labia minora (HP:0012880) | 3.33561001 |
| 14 | Febrile seizures (HP:0002373) | 3.31739217 |
| 15 | Conjunctival hamartoma (HP:0100780) | 3.23264453 |
| 16 | Volvulus (HP:0002580) | 3.22702075 |
| 17 | Central scotoma (HP:0000603) | 3.22359260 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.18841939 |
| 19 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.14340880 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.14340880 |
| 21 | Gait imbalance (HP:0002141) | 3.10395868 |
| 22 | Hematochezia (HP:0002573) | 3.03726695 |
| 23 | Dyschromatopsia (HP:0007641) | 3.03575005 |
| 24 | Gonadotropin excess (HP:0000837) | 2.98999193 |
| 25 | Biliary tract neoplasm (HP:0100574) | 2.98091560 |
| 26 | Birth length less than 3rd percentile (HP:0003561) | 2.89028611 |
| 27 | Cerebral hypomyelination (HP:0006808) | 2.88721764 |
| 28 | Tetraparesis (HP:0002273) | 2.86282829 |
| 29 | Mutism (HP:0002300) | 2.83522062 |
| 30 | Scotoma (HP:0000575) | 2.83466687 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.82582058 |
| 32 | Shoulder girdle muscle weakness (HP:0003547) | 2.81017215 |
| 33 | Limb dystonia (HP:0002451) | 2.78375278 |
| 34 | Meningioma (HP:0002858) | 2.75341545 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 2.72254610 |
| 36 | Fair hair (HP:0002286) | 2.69938472 |
| 37 | Stomach cancer (HP:0012126) | 2.67239948 |
| 38 | Breast carcinoma (HP:0003002) | 2.66501381 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.65118455 |
| 40 | Broad-based gait (HP:0002136) | 2.64883154 |
| 41 | Progressive inability to walk (HP:0002505) | 2.64830768 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.62302766 |
| 43 | Disinhibition (HP:0000734) | 2.61469747 |
| 44 | Macroorchidism (HP:0000053) | 2.60790175 |
| 45 | Poor suck (HP:0002033) | 2.52163800 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.48905463 |
| 47 | Hyperalaninemia (HP:0003348) | 2.48905463 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.48905463 |
| 49 | Nephrogenic diabetes insipidus (HP:0009806) | 2.45143777 |
| 50 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44388311 |
| 51 | Polyphagia (HP:0002591) | 2.43757786 |
| 52 | Cone-rod dystrophy (HP:0000548) | 2.42665563 |
| 53 | Abnormal hair whorl (HP:0010721) | 2.42295184 |
| 54 | Methylmalonic acidemia (HP:0002912) | 2.41605166 |
| 55 | Abnormality of macular pigmentation (HP:0008002) | 2.39806385 |
| 56 | Azoospermia (HP:0000027) | 2.39780312 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.39713449 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.39636830 |
| 59 | Amblyopia (HP:0000646) | 2.30807761 |
| 60 | Genital tract atresia (HP:0001827) | 2.30383241 |
| 61 | Facial hemangioma (HP:0000329) | 2.30111636 |
| 62 | Excessive salivation (HP:0003781) | 2.29014013 |
| 63 | Drooling (HP:0002307) | 2.29014013 |
| 64 | Hypoglycemic coma (HP:0001325) | 2.28823948 |
| 65 | Progressive macrocephaly (HP:0004481) | 2.28675818 |
| 66 | Metaphyseal dysplasia (HP:0100255) | 2.27835598 |
| 67 | Esotropia (HP:0000565) | 2.27768788 |
| 68 | Hepatocellular necrosis (HP:0001404) | 2.26820877 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.26256418 |
| 70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.25511955 |
| 71 | Aqueductal stenosis (HP:0002410) | 2.25247097 |
| 72 | Vaginal atresia (HP:0000148) | 2.24490752 |
| 73 | Neoplasm of the rectum (HP:0100743) | 2.23567155 |
| 74 | Type II lissencephaly (HP:0007260) | 2.23341344 |
| 75 | Tongue fasciculations (HP:0001308) | 2.23023317 |
| 76 | Hyperkalemia (HP:0002153) | 2.23008835 |
| 77 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.21856278 |
| 78 | Unsteady gait (HP:0002317) | 2.21774613 |
| 79 | Inappropriate behavior (HP:0000719) | 2.21178986 |
| 80 | Inability to walk (HP:0002540) | 2.18245925 |
| 81 | Long nose (HP:0003189) | 2.18121625 |
| 82 | Neoplasm of the small intestine (HP:0100833) | 2.16605644 |
| 83 | Decreased circulating renin level (HP:0003351) | 2.15738268 |
| 84 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.15327704 |
| 85 | Abnormal spermatogenesis (HP:0008669) | 2.15189012 |
| 86 | Dysautonomia (HP:0002459) | 2.14098418 |
| 87 | Abnormal biliary tract morphology (HP:0012440) | 2.12539599 |
| 88 | Poor coordination (HP:0002370) | 2.12524266 |
| 89 | CNS hypomyelination (HP:0003429) | 2.10857527 |
| 90 | Hypothermia (HP:0002045) | 2.10728046 |
| 91 | Hyperventilation (HP:0002883) | 2.08258859 |
| 92 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08083453 |
| 93 | Hip dysplasia (HP:0001385) | 2.07982375 |
| 94 | Hamartoma of the eye (HP:0010568) | 2.07340514 |
| 95 | Abnormality of the corticospinal tract (HP:0002492) | 2.07296599 |
| 96 | Chronic hepatic failure (HP:0100626) | 2.04800648 |
| 97 | Brittle hair (HP:0002299) | 2.04076920 |
| 98 | Nephronophthisis (HP:0000090) | 2.03795425 |
| 99 | Alveolar cell carcinoma (HP:0006519) | 2.03312142 |
| 100 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.99976268 |
| 101 | Abnormality of glycolysis (HP:0004366) | 1.99591903 |
| 102 | Increased serum pyruvate (HP:0003542) | 1.99591903 |
| 103 | Pancreatic fibrosis (HP:0100732) | 1.98607571 |
| 104 | Abnormal eating behavior (HP:0100738) | 1.98298033 |
| 105 | Action tremor (HP:0002345) | 1.98251837 |
| 106 | Dysdiadochokinesis (HP:0002075) | 1.97920331 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 1.97748834 |
| 108 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.96597170 |
| 109 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.96597170 |
| 110 | Epileptiform EEG discharges (HP:0011182) | 1.96252474 |
| 111 | Neoplasm of the thyroid gland (HP:0100031) | 1.95376523 |
| 112 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.94213694 |
| 113 | Truncal ataxia (HP:0002078) | 1.93873767 |
| 114 | Brushfield spots (HP:0001088) | 1.93278268 |
| 115 | Increased CSF lactate (HP:0002490) | 1.92105044 |
| 116 | Breast hypoplasia (HP:0003187) | 1.91830386 |
| 117 | Absent/shortened dynein arms (HP:0200106) | 1.91035926 |
| 118 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.91035926 |
| 119 | Constricted visual fields (HP:0001133) | 1.90624184 |
| 120 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.90575012 |
| 121 | Bladder carcinoma (HP:0002862) | 1.89947406 |
| 122 | Bladder neoplasm (HP:0009725) | 1.89947406 |
| 123 | Pancreatic cysts (HP:0001737) | 1.89153115 |
| 124 | Symptomatic seizures (HP:0011145) | 1.88894025 |
| 125 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88740777 |
| 126 | Sleep apnea (HP:0010535) | 1.87951508 |
| 127 | Increased circulating renin level (HP:0000848) | 1.87830127 |
| 128 | Abnormality of the renal medulla (HP:0100957) | 1.87785775 |
| 129 | Pelvic girdle muscle weakness (HP:0003749) | 1.87212552 |
| 130 | Abnormality of methionine metabolism (HP:0010901) | 1.86994284 |
| 131 | Vacuolated lymphocytes (HP:0001922) | 1.86676420 |
| 132 | Uterine neoplasm (HP:0010784) | 1.85963905 |
| 133 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.85959461 |
| 134 | Concave nail (HP:0001598) | 1.85782304 |
| 135 | Horizontal nystagmus (HP:0000666) | 1.85650044 |
| 136 | Restlessness (HP:0000711) | 1.85501525 |
| 137 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84035202 |
| 138 | Cerebellar dysplasia (HP:0007033) | 1.83389485 |
| 139 | Specific learning disability (HP:0001328) | 1.83386417 |
| 140 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.82004429 |
| 141 | Gaze-evoked nystagmus (HP:0000640) | 1.81753808 |
| 142 | Buphthalmos (HP:0000557) | 1.81484817 |
| 143 | Ulnar claw (HP:0001178) | 1.81026856 |
| 144 | Muscle fibrillation (HP:0010546) | 1.80295974 |
| 145 | Acute lymphatic leukemia (HP:0006721) | 1.79560996 |
| 146 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.79220237 |
| 147 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.79220237 |
| 148 | Impaired vibratory sensation (HP:0002495) | 1.79008870 |
| 149 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.78720978 |
| 150 | Glioma (HP:0009733) | 1.78672130 |
| 151 | Progressive external ophthalmoplegia (HP:0000590) | 1.76658455 |
| 152 | Hyperthyroidism (HP:0000836) | 1.75424917 |
| 153 | Emotional lability (HP:0000712) | 1.74247574 |
| 154 | Termporal pattern (HP:0011008) | 1.73551488 |
| 155 | Insidious onset (HP:0003587) | 1.73551488 |
| 156 | Generalized hypopigmentation of hair (HP:0011358) | 1.73475786 |
| 157 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.73232220 |
| 158 | Acute myeloid leukemia (HP:0004808) | 1.71672058 |
| 159 | Type I transferrin isoform profile (HP:0003642) | 1.71512857 |
| 160 | Furrowed tongue (HP:0000221) | 1.71218241 |
| 161 | Neoplasm of the adrenal cortex (HP:0100641) | 1.70773392 |
| 162 | Protruding tongue (HP:0010808) | 1.70234151 |
| 163 | Truncus arteriosus (HP:0001660) | 1.70101840 |
| 164 | Tubulointerstitial nephritis (HP:0001970) | 1.69579157 |
| 165 | Increased hepatocellular lipid droplets (HP:0006565) | 1.69011629 |
| 166 | Acute encephalopathy (HP:0006846) | 1.68837238 |
| 167 | Facial diplegia (HP:0001349) | 1.68719196 |
| 168 | Hyperglycemia (HP:0003074) | 1.68709245 |
| 169 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.68659208 |
| 170 | Rimmed vacuoles (HP:0003805) | 1.67871823 |
| 171 | Hypsarrhythmia (HP:0002521) | 1.67710184 |
| 172 | Premature ovarian failure (HP:0008209) | 1.67360666 |
| 173 | Stomatitis (HP:0010280) | 1.67108971 |
| 174 | Congenital malformation of the right heart (HP:0011723) | 1.65931174 |
| 175 | Double outlet right ventricle (HP:0001719) | 1.65931174 |
| 176 | Abnormality of vitamin B metabolism (HP:0004340) | 1.65766725 |
| 177 | Poor eye contact (HP:0000817) | 1.65207526 |
| 178 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.63213800 |
| 179 | Abnormal pupillary function (HP:0007686) | 1.62906014 |
| 180 | Molar tooth sign on MRI (HP:0002419) | 1.62600270 |
| 181 | Abnormality of midbrain morphology (HP:0002418) | 1.62600270 |
| 182 | True hermaphroditism (HP:0010459) | 1.62186239 |
| 183 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.61998774 |
| 184 | Abnormality of salivation (HP:0100755) | 1.61887079 |
| 185 | Ankle clonus (HP:0011448) | 1.60311191 |
| 186 | Ventricular fibrillation (HP:0001663) | 1.60183815 |
| 187 | Generalized myoclonic seizures (HP:0002123) | 1.59717229 |
| 188 | Retinal dysplasia (HP:0007973) | 1.59006116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.87847511 |
| 2 | EIF2AK3 | 3.75085297 |
| 3 | MAP3K9 | 3.56564277 |
| 4 | PBK | 3.50340234 |
| 5 | MARK1 | 3.32060380 |
| 6 | PNCK | 3.30033089 |
| 7 | NTRK3 | 3.09714473 |
| 8 | ARAF | 2.88109801 |
| 9 | CASK | 2.77470296 |
| 10 | NUAK1 | 2.66913974 |
| 11 | MAP3K12 | 2.50290158 |
| 12 | EPHA4 | 2.34653586 |
| 13 | MAP3K4 | 2.21406801 |
| 14 | MAP2K7 | 2.21303763 |
| 15 | MATK | 2.20791472 |
| 16 | ZAK | 2.18404691 |
| 17 | BRSK2 | 2.17949308 |
| 18 | MINK1 | 2.16222974 |
| 19 | PLK2 | 2.04624970 |
| 20 | PRKG2 | 2.03013612 |
| 21 | NME1 | 1.96402632 |
| 22 | GRK5 | 1.91947149 |
| 23 | MAPK13 | 1.71880603 |
| 24 | STK16 | 1.69346140 |
| 25 | RIPK4 | 1.63695822 |
| 26 | NLK | 1.60678137 |
| 27 | BMPR2 | 1.59629635 |
| 28 | TAF1 | 1.59484011 |
| 29 | BRAF | 1.56749977 |
| 30 | MST4 | 1.54760395 |
| 31 | KSR1 | 1.52823326 |
| 32 | TSSK6 | 1.51630300 |
| 33 | BUB1 | 1.47270138 |
| 34 | SCYL2 | 1.45875332 |
| 35 | PLK3 | 1.40727894 |
| 36 | STK3 | 1.36765586 |
| 37 | KSR2 | 1.34521460 |
| 38 | AKT3 | 1.34305771 |
| 39 | MAP2K4 | 1.30970134 |
| 40 | DYRK2 | 1.28852692 |
| 41 | BCR | 1.26235632 |
| 42 | LATS2 | 1.26205595 |
| 43 | WEE1 | 1.23993984 |
| 44 | TEC | 1.23844705 |
| 45 | PRKCG | 1.22119619 |
| 46 | STK38L | 1.21815505 |
| 47 | FGFR2 | 1.20376351 |
| 48 | TAOK3 | 1.18555992 |
| 49 | PAK6 | 1.18146608 |
| 50 | NTRK2 | 1.15203731 |
| 51 | MKNK2 | 1.14719780 |
| 52 | DYRK1A | 1.11604784 |
| 53 | MUSK | 1.11222333 |
| 54 | PLK4 | 1.03004913 |
| 55 | RAF1 | 1.01863889 |
| 56 | BMPR1B | 1.01361558 |
| 57 | TNIK | 0.98232063 |
| 58 | DYRK3 | 0.97929388 |
| 59 | CCNB1 | 0.97621622 |
| 60 | TRIM28 | 0.96381212 |
| 61 | LATS1 | 0.94878506 |
| 62 | DAPK1 | 0.94037273 |
| 63 | CAMK2A | 0.92972537 |
| 64 | MOS | 0.92713261 |
| 65 | CDK5 | 0.92276527 |
| 66 | WNK3 | 0.91399295 |
| 67 | CSNK1G2 | 0.90002264 |
| 68 | ERBB3 | 0.89907313 |
| 69 | DAPK2 | 0.89737686 |
| 70 | SRPK1 | 0.89546419 |
| 71 | KIT | 0.89270447 |
| 72 | PRKCQ | 0.87367775 |
| 73 | SIK2 | 0.87115895 |
| 74 | CDK14 | 0.86940565 |
| 75 | EIF2AK1 | 0.86675261 |
| 76 | NTRK1 | 0.86103273 |
| 77 | TRPM7 | 0.83942879 |
| 78 | FER | 0.83235921 |
| 79 | PHKG2 | 0.81355100 |
| 80 | PHKG1 | 0.81355100 |
| 81 | GRK7 | 0.81266561 |
| 82 | PINK1 | 0.80942806 |
| 83 | CSNK1G3 | 0.79778839 |
| 84 | CDK18 | 0.79103378 |
| 85 | YES1 | 0.78971794 |
| 86 | CLK1 | 0.77752834 |
| 87 | MKNK1 | 0.75666743 |
| 88 | MAP3K13 | 0.74546403 |
| 89 | CAMK2B | 0.73137853 |
| 90 | AURKA | 0.72799327 |
| 91 | CDK3 | 0.72615116 |
| 92 | CDK15 | 0.72294700 |
| 93 | CAMKK2 | 0.72045558 |
| 94 | RPS6KA4 | 0.70898407 |
| 95 | TTK | 0.70503941 |
| 96 | PTK2B | 0.70188253 |
| 97 | CDK19 | 0.69447070 |
| 98 | MAP3K2 | 0.68420326 |
| 99 | IRAK4 | 0.68346301 |
| 100 | PRKCE | 0.67222577 |
| 101 | MAP3K6 | 0.66971823 |
| 102 | PIK3CG | 0.64503202 |
| 103 | CDK11A | 0.64293321 |
| 104 | FLT3 | 0.63520976 |
| 105 | EIF2AK2 | 0.61821893 |
| 106 | CDK8 | 0.61411591 |
| 107 | GRK1 | 0.57015606 |
| 108 | IKBKB | 0.56493744 |
| 109 | FES | 0.55880289 |
| 110 | PAK3 | 0.55703059 |
| 111 | PRPF4B | 0.55156219 |
| 112 | VRK1 | 0.54927283 |
| 113 | PLK1 | 0.53478544 |
| 114 | MAP3K14 | 0.52615172 |
| 115 | ADRBK2 | 0.52111003 |
| 116 | PDK4 | 0.51270563 |
| 117 | PDK3 | 0.51270563 |
| 118 | SIK3 | 0.49676060 |
| 119 | CHEK2 | 0.49579360 |
| 120 | IRAK1 | 0.49391020 |
| 121 | OXSR1 | 0.49269633 |
| 122 | CAMK2D | 0.48731412 |
| 123 | CSNK1E | 0.48294203 |
| 124 | CAMK2G | 0.47931605 |
| 125 | ACVR1B | 0.47365192 |
| 126 | STK39 | 0.47266364 |
| 127 | CSF1R | 0.46976310 |
| 128 | RPS6KB1 | 0.46864659 |
| 129 | SGK223 | 0.46646616 |
| 130 | SGK494 | 0.46646616 |
| 131 | MAP2K1 | 0.45728924 |
| 132 | EGFR | 0.44319123 |
| 133 | PRKCI | 0.43993805 |
| 134 | MAP3K5 | 0.43809239 |
| 135 | TGFBR1 | 0.43424273 |
| 136 | UHMK1 | 0.42675850 |
| 137 | FGFR3 | 0.42477384 |
| 138 | LIMK1 | 0.42110833 |
| 139 | DMPK | 0.41990509 |
| 140 | IKBKE | 0.40829078 |
| 141 | TBK1 | 0.40604346 |
| 142 | PDK2 | 0.40442932 |
| 143 | ABL2 | 0.40117824 |
| 144 | CSNK1G1 | 0.39640404 |
| 145 | FGR | 0.39274495 |
| 146 | ABL1 | 0.39155913 |
| 147 | STK24 | 0.38930445 |
| 148 | MAPKAPK5 | 0.38851760 |
| 149 | BRSK1 | 0.38781471 |
| 150 | NEK1 | 0.38754785 |
| 151 | ERBB4 | 0.37233616 |
| 152 | MAPKAPK3 | 0.36219457 |
| 153 | PRKG1 | 0.33676975 |
| 154 | TXK | 0.29023171 |
| 155 | NEK9 | 0.28102828 |
| 156 | BRD4 | 0.27235122 |
| 157 | MARK3 | 0.24302020 |
| 158 | RPS6KB2 | 0.24050161 |
| 159 | FGFR1 | 0.23559503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73007383 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.18141819 |
| 3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.62779562 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.49571305 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.46769093 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.41369033 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39115570 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.35646517 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.32000252 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31501342 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.28306749 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.20584698 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11001913 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.06252513 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.05049776 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 2.03243475 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.03147019 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.96983908 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.95128798 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.90730266 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.89150301 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.86675840 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86590878 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85339071 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84707628 |
| 26 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.79544488 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.75314580 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.67890849 |
| 29 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67480061 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.65086525 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64887049 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62086064 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60132189 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.59050694 |
| 35 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.58854762 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.58676992 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.56545631 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54775064 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.52239358 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.50923332 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46722621 |
| 42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46141422 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42465957 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36657658 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.34615005 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32171378 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29864490 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28982639 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27060727 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25635087 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.25489744 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.23207799 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22368951 |
| 54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19973704 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.18646055 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 1.16538741 |
| 57 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.15708116 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13154484 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12156204 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10926108 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10708722 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10657092 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10448647 |
| 64 | Asthma_Homo sapiens_hsa05310 | 1.09507826 |
| 65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08835897 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06158363 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 1.05624450 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03943038 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95845658 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94246223 |
| 71 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93435096 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.93358978 |
| 73 | Purine metabolism_Homo sapiens_hsa00230 | 0.90249195 |
| 74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88828855 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87123744 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83327493 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82721959 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.80900263 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78077407 |
| 80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77283305 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77199642 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76880746 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76264607 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75503636 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.75100419 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73442705 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.72456318 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70609212 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70171473 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.69194273 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68788704 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67758476 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66540751 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66179213 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65761811 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65193888 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.63479587 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.63210129 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62934215 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62847006 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62760152 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.61056752 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.60998673 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60812422 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60529540 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60397567 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60298707 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.58919996 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57932284 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57524616 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56268957 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55983582 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.55897591 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.55711994 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.54249063 |
| 116 | Spliceosome_Homo sapiens_hsa03040 | 0.53311221 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.52946989 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52245302 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52095625 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51808353 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51244677 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50671228 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.50488248 |
| 124 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49727119 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48212114 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47600317 |
| 127 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47347049 |
| 128 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47081893 |
| 129 | Ribosome_Homo sapiens_hsa03010 | 0.46465036 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45601709 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.45281642 |
| 132 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43780053 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42763407 |
| 134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41226267 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40823147 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.40392778 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38875375 |
| 138 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38784674 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38225587 |
| 140 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.38163150 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37810780 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37618047 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37443004 |
| 144 | Mismatch repair_Homo sapiens_hsa03430 | 0.37029903 |
| 145 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36922066 |
| 146 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.36526747 |
| 147 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35501500 |
| 148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35224030 |
| 149 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34834563 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34444778 |
| 151 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32982815 |
| 152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32551324 |
| 153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31796471 |
| 154 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31602458 |
| 155 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31284985 |
| 156 | Melanoma_Homo sapiens_hsa05218 | 0.30815976 |
| 157 | Protein export_Homo sapiens_hsa03060 | 0.29452554 |

